Vår kärnverksamhet är forskning och utbildning. Ämnesområdet laboratoriemedicin knyter samman basvetenskaplig forskning, klinisk forskning och vård. Institutionens roll är att överföra och förädla medicinsk kunskap till vården i samverkan mellan akademi, vård och industri.

Kalender

Datum Event
22 nov 2017 Open Scientific Seminar Series: Strengthening global health research and its policy implications in Sweden: birth and future of Swedish Institute for Global Health Transformation (SIGHT) at Royal Academy of Sciences
24 nov 2017 Disputation - Ghazal Heidari-Hamedani
29 nov 2017 Open Scientific Seminar Series: A prospective 6-month study on efavirenz based HIV-therapy in Ugandan children: preliminary results on clinical outcome, resistance patterns, drug disposition and pharmacogenetics
01 dec 2017 Disputation - Tumaini Nagu
06 dec 2017 Seminarium - Reparative endogenous pluripotent stem cells, Muse cells, may shift the paradigm of regenerative medicine
06 dec 2017 Open Scientific Seminar Series: Report from from 15th International Congress on of Clinical Therapeutic Monitoring and Clinical Toxicology. Kyoto, Sep.er 24th to 27th: reflections on analytical and clinical breakthroughs
14 dec 2017 Halvtidskontroll - Johan Holm
10 jan 2018 Open Scientific Seminar Series: Dagens och framtidens roll för läkemedelskommittéerna i Sverige
17 jan 2018 Open Scientific Seminar Series: The role of neurosteroids and GABA-receptors in disease conditions: perspectives of novel mechanisms for pharmacological interventions
24 jan 2018 Open Scientific Seminar Series: Genetic makeup of Shiga toxin-producing Escherichia coli in relation to clinical symptoms and duration of bacterial shedding
31 jan 2018 Open Scientific Seminar Series: Increased availability of paracetamol in Sweden and increased incidence of poisoning: epidemiological considerations, international experience and regulatory implications
07 feb 2018 Open Scientific Seminar Series: ENABLE – an Innovative Medicines Initiative to advance the development of novel antibiotics by means of a collaborative public-private partnership